Evaluation of commercial assays for vancomycin and aminoglycosides in serum: A comparison of accuracy and precision based on external quality assessment

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 1, 2003, Pages 78-82

  Wilson, John F ^a   Davis, Alan C ^b   Tobin, Caroline M ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Amikacin; Gentamicin; Immunoassays; Netilmicin; Tobramycin

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; NETILMICIN; TOBRAMYCIN; VANCOMYCIN;

ACCURACY; ARTICLE; CLINICAL CHEMISTRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG DETERMINATION; DRUG MONITORING; HUMAN; INTERMETHOD COMPARISON; KIDNEY FUNCTION; LABORATORY TEST; PATIENT MONITORING; QUALITATIVE ANALYSIS; STANDARDIZATION;

EID: 0038262684     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg296     Document Type: Article

References (8)

1. Powell S. H., Thompson, W. L., Luthe, M. A. et al. (1983). Once-daily versus continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin and tobramycin. Journal of Infectious Diseases 147, 918-32.
2. Reeves, D. S., MacGowan, A. P., Holt, H. A. et al. (1995). Therapeutic monitoring of antimicrobials: a summary of the information presented at the UK NEQAS for Antibiotic Assays meeting for participants, October, 1993. Journal of Antimicrobial Chemotherapy 35, 213-26.
3. British Medical Association and Royal Pharmaceutical Society of Great Britain (2002). British National Formulary, Number 44 (October 2002). British Medical Association and Royal Pharmaceutical Society of Great Britain, London, UK.
4. Tobin, C. M., Darville J. M., Thomson A. H. et al. (2002). Vancomycin therapeutic drug monitoring (TDM): Is there a consensus view? The results of a UK National External Quality Assessment Scheme for Antibiotic Assays (UK NEQAS) questionnaire. Journal of Antimicrobial Chemotherapy 50, 713-8.
5. Healy, M. J. R. (1979). Outliers in clinical chemistry quality-control schemes. Clinical Chemistry 25, 775-7.
6. Somerville, A. L., Wright, D. H. & Rotschafer, J. C. (1999). Implications of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease. Pharmacotherapy 19, 702-7.
7. Trujillo, T. N., Sowinski, K. M., Venezia, R. A. et al. (1999). Vancomycin assay performance in patients with acute renal failure. Intensive Care Medicine 25, 1291-6.
8. Fraser, C. G. (1987). Desirable standards of performance for therapeutic drug monitoring. Clinical Chemistry 33, 387-9.